Simona Aschero

478 total citations
8 papers, 341 citations indexed

About

Simona Aschero is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Simona Aschero has authored 8 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hematology and 3 papers in Oncology. Recurrent topics in Simona Aschero's work include Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Chromatin Remodeling and Cancer (2 papers). Simona Aschero is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Chromatin Remodeling and Cancer (2 papers). Simona Aschero collaborates with scholars based in Italy, Netherlands and Slovakia. Simona Aschero's co-authors include Franca Fagioli, Katia Mareschi, Enrico Madon, Massimo Aglietta, Loretta Gammaitoni, Deborah Rustichelli, Ivana Ferrero, Paola Omedè, Benedetta Bussolati and Luigia Monitillo and has published in prestigious journals such as Blood, Cancer Letters and Leukemia.

In The Last Decade

Simona Aschero

8 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Aschero Italy	4	210	142	114	47	47	8	341
Veena Krishnappa United States	8	284 1.4×	179 1.3×	136 1.2×	41 0.9×	64 1.4×	11	447
Jessica Cuerquis Canada	12	198 0.9×	171 1.2×	128 1.1×	49 1.0×	44 0.9×	17	529
Abhishek Harichandan Germany	9	186 0.9×	126 0.9×	102 0.9×	29 0.6×	24 0.5×	11	327
Gabriele Brachtl Austria	11	191 0.9×	129 0.9×	56 0.5×	42 0.9×	24 0.5×	15	479
Johannes Leibacher Germany	5	232 1.1×	181 1.3×	130 1.1×	32 0.7×	39 0.8×	6	464
María Fernández-García Spain	8	203 1.0×	109 0.8×	78 0.7×	36 0.8×	33 0.7×	15	315
Daniela Thaler Austria	5	170 0.8×	206 1.5×	113 1.0×	60 1.3×	61 1.3×	6	447
Matthew Cook Australia	4	216 1.0×	97 0.7×	110 1.0×	39 0.8×	32 0.7×	6	327
Dominic Sweeney United Kingdom	7	231 1.1×	168 1.2×	201 1.8×	21 0.4×	60 1.3×	8	407
Zhidan Tu China	11	128 0.6×	158 1.1×	67 0.6×	25 0.5×	31 0.7×	13	480

Countries citing papers authored by Simona Aschero

Since Specialization

Citations

This map shows the geographic impact of Simona Aschero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Aschero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Aschero more than expected).

Fields of papers citing papers by Simona Aschero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Aschero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Aschero. The network helps show where Simona Aschero may publish in the future.

Co-authorship network of co-authors of Simona Aschero

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Aschero. A scholar is included among the top collaborators of Simona Aschero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Aschero. Simona Aschero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bringhen, Sara, Stefania Oliva, Anna Marina Liberati, et al.. (2017). Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study. Clinical Lymphoma Myeloma & Leukemia. 17(1). e59–e59. 2 indexed citations

Bringhen, Sara, Davide Rossi, Alessandra Larocca, et al.. (2015). Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCyd) in Elderly Newly Diagnosed Multiple Myeloma Patients: Results of a Phase 2 Study. Blood. 126(23). 1828–1828. 4 indexed citations

Caltagirone, S, Marina Ruggeri, Simona Aschero, et al.. (2014). Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. Haematologica. 99(10). 1611–1617. 17 indexed citations

Conticello, Concetta, Lucia Pantani, Vittorio Montefusco, et al.. (2013). Carfilzomib, Cyclophosphamide and dexamethasone (CCD) for newly diagnosed multiple myeloma (MM) patients: initial results of a multicenter, open label phase II study. 3 indexed citations

Lamorte, Sara, Simone Ferrero, Simona Aschero, et al.. (2011). Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia. 26(5). 1081–1090. 58 indexed citations

Pezzolo, Annalisa, Simona Coco, Alessandro Raso, et al.. (2011). Loss of 10q26.1–q26.3 in association with 7q34–q36.3 gain or 17q24.3–q25.3 gain predict poor outcome in pediatric medulloblastoma. Cancer Letters. 308(2). 215–224. 3 indexed citations

Aschero, Simona, Stefano Vallero, Isabella Morra, et al.. (2010). A complex karyotype including a t(2;11) in a paediatric ependymoma: case report and review of the literature. Journal of Neuro-Oncology. 99(1). 141–146. 1 indexed citations

Mareschi, Katia, Ivana Ferrero, Deborah Rustichelli, et al.. (2005). Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. Journal of Cellular Biochemistry. 97(4). 744–754. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact